Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.

Saved in:
Bibliographic Details
Title: Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Authors: Stewart I; National Heart and Lung Institute, Imperial College London, UK; NIHR Imperial Biomedical Research Centre, Imperial College London, UK. Electronic address: iain.stewart@imperial.ac.uk., Jacob J; Satsuma Lab, Centre for Medical Imaging Computing, University College London, UK; UCL Respiratory, University College London, UK; University College London Hospitals NHS Foundation Trust, UK., Porter JC; UCL Respiratory, University College London, UK; University College London Hospitals NHS Foundation Trust, UK., Liu B; National Heart and Lung Institute, Imperial College London, UK., Tatler AL; School of Medicine, University of Nottingham, UK; NIHR Nottingham Biomedical Research Centre, University of Nottingham, UK., Gomez N; School of Medicine, University of Nottingham, UK; NIHR Nottingham Biomedical Research Centre, University of Nottingham, UK., Pugh MR; Institute of Immunology and Immunotherapy, University of Birmingham, UK., John AE; National Heart and Lung Institute, Imperial College London, UK., Allen RJ; Department of Health Sciences, University of Leicester, UK; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Blaikley JF; Manchester University NHS Foundation Trust, UK; School of Biological Sciences, University of Manchester, UK., Chaudhuri N; Ulster University, UK., Denneny E; UCL Respiratory, University College London, UK., Fabbri L; National Heart and Lung Institute, Imperial College London, UK; Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, UK., George PM; National Heart and Lung Institute, Imperial College London, UK; Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, UK., Guillen-Guio B; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Gooptu B; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Hall IP; School of Medicine, University of Nottingham, UK; NIHR Nottingham Biomedical Research Centre, University of Nottingham, UK., Ho LP; Oxford University Hospitals NHS Foundation Trust, UK; Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, UK., Jarrold I; Asthma + Lung UK, UK., Johnson S; School of Medicine, University of Nottingham, UK., Jones MG; University Hospital Southampton NHS Foundation Trust, UK., Khan F; University Hospitals of Leicester NHS Trust, UK., Mehta P; UCL Respiratory, University College London, UK., Mitchell J; National Heart and Lung Institute, Imperial College London, UK; NIHR Imperial Biomedical Research Centre, Imperial College London, UK., Molyneaux PL; National Heart and Lung Institute, Imperial College London, UK; NIHR Imperial Biomedical Research Centre, Imperial College London, UK., Pearl JE; Department of Respiratory Sciences, University of Leicester, UK., Piper Hanley K; School of Medical Sciences, University of Manchester, UK., Platé M; UCL Respiratory, University College London, UK., Quinn V; National Heart and Lung Institute, Imperial College London, UK., Rivera-Ortega P; Manchester University NHS Foundation Trust, UK., Saunders LC; School of Medicine & Population Health, University of Sheffield, UK., Smith DJF; National Heart and Lung Institute, Imperial College London, UK; NIHR Imperial Biomedical Research Centre, Imperial College London, UK., Spears M; NHS Tayside & University of Dundee, UK., Spencer LG; Liverpool University Hospitals NHS Foundation Trust, UK., Stanel SC; Manchester University NHS Foundation Trust, UK; School of Biological Sciences, University of Manchester, UK., Thompson AAR; School of Medicine & Population Health, University of Sheffield, UK; NIHR Sheffield Biomedical Research Centre, University of Sheffield, UK., Walsh S; Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, UK., Wild JM; School of Medicine & Population Health, University of Sheffield, UK., Wootton DG; Liverpool University Hospitals NHS Foundation Trust, UK., Docherty AB; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, UK., Gleeson F; Oxford University Hospitals NHS Foundation Trust, UK., Greenhalf W; Liverpool University Hospitals NHS Foundation Trust, UK; University of Liverpool, UK., Harrison EM; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, UK., Lone N; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, UK., Quint J; National Heart and Lung Institute, Imperial College London, UK., Maslova A; Sysmex R&D Centre UK, UK., Pohl M; Sysmex R&D Centre UK, UK., Stephens A; Sysmex R&D Centre UK, UK., Young S; Sysmex R&D Centre UK, UK., Singapuri A; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Shikotra A; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Sereno M; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Saunders RM; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Richardson M; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Raman B; Oxford University Hospitals NHS Foundation Trust, UK., Poinasamy K; Asthma + Lung UK, UK., McAuley HJC; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Marks M; London School of Hygiene & Tropical Medicine, UK., Leavy OC; Department of Health Sciences, University of Leicester, UK., Houchen-Wolloff L; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Horsley A; Manchester University NHS Foundation Trust, UK., Harris VC; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Greening N; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Evans RA; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Elneima O; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Chalmers JD; NHS Tayside & University of Dundee, UK., Brightling CE; NIHR Leicester Biomedical Research Centre, University of Leicester, UK; School of Biological Sciences, University of Manchester, UK; University Hospitals of Leicester NHS Trust, UK., Chambers RC; UCL Respiratory, University College London, UK., Wain LV; Department of Health Sciences, University of Leicester, UK; NIHR Leicester Biomedical Research Centre, University of Leicester, UK., Jenkins RG; National Heart and Lung Institute, Imperial College London, UK; NIHR Imperial Biomedical Research Centre, Imperial College London, UK; Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, UK.
Corporate Authors: PHOSP-COVID Collaborative Group and the UKILD Consortium
Source: EBioMedicine [EBioMedicine] 2026 Feb; Vol. 124, pp. 106134. Date of Electronic Publication: 2026 Jan 24.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3964
DOI:10.1016/j.ebiom.2026.106134